Skip to main content
Erschienen in: European Radiology 8/2023

09.03.2023 | Neuro

A comprehensive characterization of hippocampal feature ensemble serves as individualized brain signature for Alzheimer’s disease: deep learning analysis in 3238 participants worldwide

verfasst von: Yiyu Zhang, Hongming Li, Qiang Zheng

Erschienen in: European Radiology | Ausgabe 8/2023

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Hippocampal characterization is one of the most significant hallmarks of Alzheimer’s disease (AD); rather, the single-level feature is insufficient. A comprehensive hippocampal characterization is pivotal for developing a well-performing biomarker for AD. To verify whether a comprehensive characterization of hippocampal features of gray matter volume, segmentation probability, and radiomics features could better distinguish AD from normal control (NC), and to investigate whether the classification decision score could serve as a robust and individualized brain signature.

Methods

A total of 3238 participants’ structural MRI from four independent databases were employed to conduct a 3D residual attention network (3DRA-Net) to classify NC, mild cognitive impairment (MCI), and AD. The generalization was validated under inter-database cross-validation. The neurobiological basis of the classification decision score as a neuroimaging biomarker was systematically investigated by association with clinical profiles, as well as longitudinal trajectory analysis to reveal AD progression. All image analyses were performed only upon the single modality of T1-weighted MRI.

Results

Our study exhibited an outstanding performance (ACC = 91.6%, AUC = 0.95) of the comprehensive characterization of hippocampal features in distinguishing AD (n = 282) from NC (n = 603) in Alzheimer’s Disease Neuroimaging Initiative cohort, and ACC = 89.2% and AUC = 0.93 under external validation. More importantly, the constructed score was significantly correlated with clinical profiles (p < 0.05), and dynamically altered over the AD longitudinal progression, provided compelling evidence of a solid neurobiological basis.

Conclusions

This systemic study highlights the potential of the comprehensive characterization of hippocampal features to provide an individualized, generalizable, and biologically plausible neuroimaging biomarker for early detection of AD.

Key Points

• The comprehensive characterization of hippocampal features exhibited ACC = 91.6% (AUC = 0.95) in classifying AD from NC under intra-database cross-validation, and ACC = 89.2% (AUC = 0.93) in external validation.
• The constructed classification score was significantly associated with clinical profiles, and dynamically altered over the AD longitudinal progression, which highlighted its potential of being an individualized, generalizable, and biologically plausible neuroimaging biomarker for early detection of AD.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Querfurth HW, Laferla FM (2010) Alzheimer’s disease. N Engl J Med 362:329PubMed Querfurth HW, Laferla FM (2010) Alzheimer’s disease. N Engl J Med 362:329PubMed
2.
Zurück zum Zitat Petersen RC (2011) Mild cognitive impairment. N Engl J Med 364:2227–2234PubMed Petersen RC (2011) Mild cognitive impairment. N Engl J Med 364:2227–2234PubMed
4.
Zurück zum Zitat Ezzati A, Katz MJ, Zammit AR et al (2016) Differential association of left and right hippocampal volumes with verbal episodic and spatial memory in older adults. Neuropsychologia 93:380–385PubMedPubMedCentral Ezzati A, Katz MJ, Zammit AR et al (2016) Differential association of left and right hippocampal volumes with verbal episodic and spatial memory in older adults. Neuropsychologia 93:380–385PubMedPubMedCentral
5.
Zurück zum Zitat Wen J, Thibeau-Sutre E, Diaz-Melo M et al (2020) Convolutional neural networks for classification of Alzheimer’s disease: overview and reproducible evaluation. Med Image Anal 63:101694PubMed Wen J, Thibeau-Sutre E, Diaz-Melo M et al (2020) Convolutional neural networks for classification of Alzheimer’s disease: overview and reproducible evaluation. Med Image Anal 63:101694PubMed
6.
Zurück zum Zitat Park HY, Suh CH, Heo H, Shim WH, Kim SJ (2022) Diagnostic performance of hippocampal volumetry in Alzheimer’s disease or mild cognitive impairment: a meta-analysis. Eur Radiol 32:6979–6991PubMed Park HY, Suh CH, Heo H, Shim WH, Kim SJ (2022) Diagnostic performance of hippocampal volumetry in Alzheimer’s disease or mild cognitive impairment: a meta-analysis. Eur Radiol 32:6979–6991PubMed
7.
Zurück zum Zitat Olsen RK, Moses SN, Riggs L, Ryan JD (2012) The hippocampus supports multiple cognitive processes through relational binding and comparison. Front Hum Neurosci 6:146PubMedPubMedCentral Olsen RK, Moses SN, Riggs L, Ryan JD (2012) The hippocampus supports multiple cognitive processes through relational binding and comparison. Front Hum Neurosci 6:146PubMedPubMedCentral
8.
Zurück zum Zitat Lin W, Tong T, Gao Q et al (2018) Convolutional neural networks-based MRI image analysis for the Alzheimer’s disease prediction from mild cognitive impairment. Front Neurosci 12:777PubMedPubMedCentral Lin W, Tong T, Gao Q et al (2018) Convolutional neural networks-based MRI image analysis for the Alzheimer’s disease prediction from mild cognitive impairment. Front Neurosci 12:777PubMedPubMedCentral
9.
Zurück zum Zitat Qiu S, Joshi PS, Miller MI et al (2020) Development and validation of an interpretable deep learning framework for Alzheimer’s disease classification. Brain 143:1920–1933PubMedPubMedCentral Qiu S, Joshi PS, Miller MI et al (2020) Development and validation of an interpretable deep learning framework for Alzheimer’s disease classification. Brain 143:1920–1933PubMedPubMedCentral
10.
Zurück zum Zitat Jin D, Zhou B, Han Y et al (2020) Generalizable, Reproducible, and neuroscientifically interpretable imaging biomarkers for Alzheimer’s disease. Adv Sci 7:2000675 Jin D, Zhou B, Han Y et al (2020) Generalizable, Reproducible, and neuroscientifically interpretable imaging biomarkers for Alzheimer’s disease. Adv Sci 7:2000675
11.
Zurück zum Zitat Jack CR Jr, Barkhof F, Bernstein MA et al (2011) Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer’s disease. Alzheimers Dement 7(474–485):e474 Jack CR Jr, Barkhof F, Bernstein MA et al (2011) Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer’s disease. Alzheimers Dement 7(474–485):e474
12.
Zurück zum Zitat Zheng Q, Wu Y, Fan Y (2018) Integrating semi-supervised and supervised learning methods for label fusion in multi-atlas based image segmentation. Front Neuroinform 12:69PubMedPubMedCentral Zheng Q, Wu Y, Fan Y (2018) Integrating semi-supervised and supervised learning methods for label fusion in multi-atlas based image segmentation. Front Neuroinform 12:69PubMedPubMedCentral
13.
Zurück zum Zitat Li H, Habes M, Wolk DA, Fan Y, AsDN I (2019) A deep learning model for early prediction of Alzheimer’s disease dementia based on hippocampal magnetic resonance imaging data. Alzheimers Dement 15:1059–1070PubMedPubMedCentral Li H, Habes M, Wolk DA, Fan Y, AsDN I (2019) A deep learning model for early prediction of Alzheimer’s disease dementia based on hippocampal magnetic resonance imaging data. Alzheimers Dement 15:1059–1070PubMedPubMedCentral
14.
Zurück zum Zitat Zhao K, Ding Y, Han Y et al (2020) Independent and reproducible hippocampal radiomic biomarkers for multisite Alzheimer’s disease: diagnosis, longitudinal progress and biological basis. Sci Bull 65:1103–1113 Zhao K, Ding Y, Han Y et al (2020) Independent and reproducible hippocampal radiomic biomarkers for multisite Alzheimer’s disease: diagnosis, longitudinal progress and biological basis. Sci Bull 65:1103–1113
15.
Zurück zum Zitat Zhang Y, Zheng Q, Zhao K et al (2021) Early diagnosis of alzheimer's disease using 3D residual attention network based on hippocampal multi-indices feature fusion. Pattern Recognition and Computer Vision: 4th Chinese Conference, PRCV 2021, Beijing, China, October 29–November 1, 2021, Proceedings, Part III 4. Springer, pp 449–457 Zhang Y, Zheng Q, Zhao K et al (2021) Early diagnosis of alzheimer's disease using 3D residual attention network based on hippocampal multi-indices feature fusion. Pattern Recognition and Computer Vision: 4th Chinese Conference, PRCV 2021, Beijing, China, October 29–November 1, 2021, Proceedings, Part III 4. Springer, pp 449–457
16.
Zurück zum Zitat Gaser C, Dahnke R, Thompson PM, Kurth F, Luders E (2022) CAT-a computational anatomy toolbox for the analysis of structural MRI data. BioRxiv:2022.2006. 2011.495736 Gaser C, Dahnke R, Thompson PM, Kurth F, Luders E (2022) CAT-a computational anatomy toolbox for the analysis of structural MRI data. BioRxiv:2022.2006. 2011.495736
17.
Zurück zum Zitat Avants BB, Tustison NJ, Song G, Cook PA, Klein A, Gee JC (2011) A reproducible evaluation of ANTs similarity metric performance in brain image registration. Neuroimage 54:2033–2044PubMed Avants BB, Tustison NJ, Song G, Cook PA, Klein A, Gee JC (2011) A reproducible evaluation of ANTs similarity metric performance in brain image registration. Neuroimage 54:2033–2044PubMed
18.
Zurück zum Zitat He K, Zhang X, Ren S, Sun J (2015) Delving deep into rectifiers: surpassing human-level performance on imagenet classification. In: Proceedings of the IEEE international conference on computer vision, ICCV 2015, pp 1026–1034 He K, Zhang X, Ren S, Sun J (2015) Delving deep into rectifiers: surpassing human-level performance on imagenet classification. In: Proceedings of the IEEE international conference on computer vision, ICCV 2015, pp 1026–1034
19.
Zurück zum Zitat Kingma DP, Ba J (2014) Adam: a method for stochastic optimization. arXiv:14126980 Kingma DP, Ba J (2014) Adam: a method for stochastic optimization. arXiv:14126980
20.
Zurück zum Zitat Green RC, Roberts JS, Cupples LA et al (2009) Disclosure of APOE genotype for risk of Alzheimer’s disease. N Engl J Med 361:245–254PubMedPubMedCentral Green RC, Roberts JS, Cupples LA et al (2009) Disclosure of APOE genotype for risk of Alzheimer’s disease. N Engl J Med 361:245–254PubMedPubMedCentral
21.
Zurück zum Zitat Seshadri S, Fitzpatrick AL, Ikram MA et al (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303:1832–1840PubMedPubMedCentral Seshadri S, Fitzpatrick AL, Ikram MA et al (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303:1832–1840PubMedPubMedCentral
22.
Zurück zum Zitat Ashford MT, Veitch DP, Neuhaus J, Nosheny RL, Tosun D, Weiner MW (2021) The search for a convenient procedure to detect one of the earliest signs of Alzheimer’s disease: a systematic review of the prediction of brain amyloid status. Alzheimers Dement 17:866–887PubMed Ashford MT, Veitch DP, Neuhaus J, Nosheny RL, Tosun D, Weiner MW (2021) The search for a convenient procedure to detect one of the earliest signs of Alzheimer’s disease: a systematic review of the prediction of brain amyloid status. Alzheimers Dement 17:866–887PubMed
23.
Zurück zum Zitat Schindler SE, Gray JD, Gordon BA et al (2018) Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging. Alzheimers Dement 14:1460–1469PubMedPubMedCentral Schindler SE, Gray JD, Gordon BA et al (2018) Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging. Alzheimers Dement 14:1460–1469PubMedPubMedCentral
24.
Zurück zum Zitat Shaw LM, Waligorska T, Fields L et al (2018) Derivation of cutoffs for the Elecsys amyloid β (1–42) assay in Alzheimer’s disease. Alzheimer’s Dement 10:698–705 Shaw LM, Waligorska T, Fields L et al (2018) Derivation of cutoffs for the Elecsys amyloid β (1–42) assay in Alzheimer’s disease. Alzheimer’s Dement 10:698–705
25.
Zurück zum Zitat Zhuo J, Zhang Y, Liu Y et al (2021) New trajectory of clinical and biomarker changes in sporadic Alzheimer’s disease. Cereb Cortex 31:3363–3373PubMed Zhuo J, Zhang Y, Liu Y et al (2021) New trajectory of clinical and biomarker changes in sporadic Alzheimer’s disease. Cereb Cortex 31:3363–3373PubMed
26.
Zurück zum Zitat Palmqvist S, Tideman P, Cullen N et al (2021) Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures. Nat Med 27:1034–1042PubMed Palmqvist S, Tideman P, Cullen N et al (2021) Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures. Nat Med 27:1034–1042PubMed
27.
Zurück zum Zitat Liu M, Li F, Yan H et al (2020) A multi-model deep convolutional neural network for automatic hippocampus segmentation and classification in Alzheimer’s disease. Neuroimage 208:116459PubMed Liu M, Li F, Yan H et al (2020) A multi-model deep convolutional neural network for automatic hippocampus segmentation and classification in Alzheimer’s disease. Neuroimage 208:116459PubMed
28.
Zurück zum Zitat Li F, Liu M, AsDN I (2019) A hybrid convolutional and recurrent neural network for hippocampus analysis in Alzheimer’s disease. J Neurosci Methods 323:108–118PubMed Li F, Liu M, AsDN I (2019) A hybrid convolutional and recurrent neural network for hippocampus analysis in Alzheimer’s disease. J Neurosci Methods 323:108–118PubMed
29.
Zurück zum Zitat He K, Zhang X, Ren S, Sun J (2016) Deep residual learning for image recognition. In: Proceedings of the IEEE conference on computer vision and pattern recognition, CVPR 2016, pp 770–778 He K, Zhang X, Ren S, Sun J (2016) Deep residual learning for image recognition. In: Proceedings of the IEEE conference on computer vision and pattern recognition, CVPR 2016, pp 770–778
30.
Zurück zum Zitat Zhao K, Ding Y, Wang P et al (2017) Early classification of Alzheimer’s disease using hippocampal texture from structural MRI. In: Medical imaging 2017: biomedical applications in molecular, structural, and functional imaging, SPIE 2017, pp 625–631 Zhao K, Ding Y, Wang P et al (2017) Early classification of Alzheimer’s disease using hippocampal texture from structural MRI. In: Medical imaging 2017: biomedical applications in molecular, structural, and functional imaging, SPIE 2017, pp 625–631
31.
Zurück zum Zitat Beheshti I, Demirel H, AsDN I (2016) Feature-ranking-based Alzheimer’s disease classification from structural MRI. Magn Reson Imaging 34:252–263PubMed Beheshti I, Demirel H, AsDN I (2016) Feature-ranking-based Alzheimer’s disease classification from structural MRI. Magn Reson Imaging 34:252–263PubMed
32.
Zurück zum Zitat Egan MF, Kost J, Tariot PN et al (2018) Randomized trial of verubecestat for mild-to-moderate Alzheimer’s disease. N Engl J Med 378:1691–1703PubMedPubMedCentral Egan MF, Kost J, Tariot PN et al (2018) Randomized trial of verubecestat for mild-to-moderate Alzheimer’s disease. N Engl J Med 378:1691–1703PubMedPubMedCentral
33.
Zurück zum Zitat Honig LS, Vellas B, Woodward M et al (2018) Trial of solanezumab for mild dementia due to Alzheimer’s disease. N Engl J Med 378:321–330PubMed Honig LS, Vellas B, Woodward M et al (2018) Trial of solanezumab for mild dementia due to Alzheimer’s disease. N Engl J Med 378:321–330PubMed
34.
Zurück zum Zitat Ding Y, Zhao K, Che T et al (2021) Quantitative radiomic features as new biomarkers for Alzheimer’s disease: an amyloid PET study. Cereb Cortex 31:3950–3961PubMed Ding Y, Zhao K, Che T et al (2021) Quantitative radiomic features as new biomarkers for Alzheimer’s disease: an amyloid PET study. Cereb Cortex 31:3950–3961PubMed
35.
Zurück zum Zitat Zhao K, Zheng Q, Dyrba M et al (2022) Regional radiomics similarity networks reveal distinct subtypes and abnormality patterns in mild cognitive impairment. Advanced Science 9:2104538PubMedPubMedCentral Zhao K, Zheng Q, Dyrba M et al (2022) Regional radiomics similarity networks reveal distinct subtypes and abnormality patterns in mild cognitive impairment. Advanced Science 9:2104538PubMedPubMedCentral
36.
Zurück zum Zitat Zhao K, Zheng Q, Che T et al (2021) Regional radiomics similarity networks (R2SNs) in the human brain: reproducibility, small-world properties and a biological basis. Netw Neurosci 5:783–797PubMedPubMedCentral Zhao K, Zheng Q, Che T et al (2021) Regional radiomics similarity networks (R2SNs) in the human brain: reproducibility, small-world properties and a biological basis. Netw Neurosci 5:783–797PubMedPubMedCentral
37.
Zurück zum Zitat Zhao K, Lin J, Dyrba M et al (2022) Coupling of the spatial distributions between sMRI and PET reveals the progression of Alzheimer’s disease. Netw Neurosci 1–26 Zhao K, Lin J, Dyrba M et al (2022) Coupling of the spatial distributions between sMRI and PET reveals the progression of Alzheimer’s disease. Netw Neurosci 1–26
38.
Zurück zum Zitat Woo C-W, Chang LJ, Lindquist MA, Wager TD (2017) Building better biomarkers: brain models in translational neuroimaging. Nat Neurosci 20:365–377PubMedPubMedCentral Woo C-W, Chang LJ, Lindquist MA, Wager TD (2017) Building better biomarkers: brain models in translational neuroimaging. Nat Neurosci 20:365–377PubMedPubMedCentral
39.
Zurück zum Zitat Varoquaux G (2018) Cross-validation failure: small sample sizes lead to large error bars. Neuroimage 180:68–77PubMed Varoquaux G (2018) Cross-validation failure: small sample sizes lead to large error bars. Neuroimage 180:68–77PubMed
40.
Zurück zum Zitat Reiss AB, Arain HA, Stecker MM, Siegart NM, Kasselman LJ (2018) Amyloid toxicity in Alzheimer’s disease. Rev Neurosci 29:613–627PubMed Reiss AB, Arain HA, Stecker MM, Siegart NM, Kasselman LJ (2018) Amyloid toxicity in Alzheimer’s disease. Rev Neurosci 29:613–627PubMed
41.
Zurück zum Zitat Jack CR Jr, Knopman DS, Jagust WJ et al (2013) Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 12:207–216PubMedPubMedCentral Jack CR Jr, Knopman DS, Jagust WJ et al (2013) Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 12:207–216PubMedPubMedCentral
42.
Zurück zum Zitat Nussbaum JM, Schilling S, Cynis H et al (2012) Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β. Nature 485:651–655PubMedPubMedCentral Nussbaum JM, Schilling S, Cynis H et al (2012) Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β. Nature 485:651–655PubMedPubMedCentral
43.
Zurück zum Zitat Suárez-Calvet M, Karikari TK, Ashton NJ et al (2020) Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detected. EMBO Mol Med 12:e12921PubMedPubMedCentral Suárez-Calvet M, Karikari TK, Ashton NJ et al (2020) Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detected. EMBO Mol Med 12:e12921PubMedPubMedCentral
44.
Zurück zum Zitat Popuri K, Ma D, Wang L, Beg MF (2020) Using machine learning to quantify structural MRI neurodegeneration patterns of Alzheimer’s disease into dementia score: Independent validation on 8,834 images from ADNI, AIBL, OASIS, and MIRIAD databases. Hum Brain Mapp 41:4127–4147PubMedPubMedCentral Popuri K, Ma D, Wang L, Beg MF (2020) Using machine learning to quantify structural MRI neurodegeneration patterns of Alzheimer’s disease into dementia score: Independent validation on 8,834 images from ADNI, AIBL, OASIS, and MIRIAD databases. Hum Brain Mapp 41:4127–4147PubMedPubMedCentral
45.
Zurück zum Zitat Spasov S, Passamonti L, Duggento A, Lio P, Toschi N, AsDN I (2019) A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer’s disease. Neuroimage 189:276–287PubMed Spasov S, Passamonti L, Duggento A, Lio P, Toschi N, AsDN I (2019) A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer’s disease. Neuroimage 189:276–287PubMed
46.
Zurück zum Zitat El-Sappagh S, Abuhmed T, Islam SR, Kwak KS (2020) Multimodal multitask deep learning model for Alzheimer’s disease progression detection based on time series data. Neurocomputing 412:197–215 El-Sappagh S, Abuhmed T, Islam SR, Kwak KS (2020) Multimodal multitask deep learning model for Alzheimer’s disease progression detection based on time series data. Neurocomputing 412:197–215
47.
Zurück zum Zitat Liu M, Cheng D, Wang K, Wang Y (2018) Multi-modality cascaded convolutional neural networks for Alzheimer’s disease diagnosis. Neuroinformatics 16:295–308PubMed Liu M, Cheng D, Wang K, Wang Y (2018) Multi-modality cascaded convolutional neural networks for Alzheimer’s disease diagnosis. Neuroinformatics 16:295–308PubMed
48.
Zurück zum Zitat Gupta Y, Lama RK, Kwon G-R et al (2019) Prediction and classification of Alzheimer’s disease based on combined features from apolipoprotein-E genotype, cerebrospinal fluid, MR, and FDG-PET imaging biomarkers. Front Comput Neurosci 13:72PubMedPubMedCentral Gupta Y, Lama RK, Kwon G-R et al (2019) Prediction and classification of Alzheimer’s disease based on combined features from apolipoprotein-E genotype, cerebrospinal fluid, MR, and FDG-PET imaging biomarkers. Front Comput Neurosci 13:72PubMedPubMedCentral
49.
Zurück zum Zitat Hansson O (2021) Biomarkers for neurodegenerative diseases. Nat Med 27:954–963PubMed Hansson O (2021) Biomarkers for neurodegenerative diseases. Nat Med 27:954–963PubMed
50.
Zurück zum Zitat Chandra A, Dervenoulas G, Politis M (2019) Magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment. J Neurol 266:1293–1302PubMed Chandra A, Dervenoulas G, Politis M (2019) Magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment. J Neurol 266:1293–1302PubMed
51.
Zurück zum Zitat Lehéricy S, Marjanska M, Mesrob L, Sarazin M, Kinkingnehun S (2007) Magnetic resonance imaging of Alzheimer’s disease. Eur Radiol 17:347–362PubMed Lehéricy S, Marjanska M, Mesrob L, Sarazin M, Kinkingnehun S (2007) Magnetic resonance imaging of Alzheimer’s disease. Eur Radiol 17:347–362PubMed
Metadaten
Titel
A comprehensive characterization of hippocampal feature ensemble serves as individualized brain signature for Alzheimer’s disease: deep learning analysis in 3238 participants worldwide
verfasst von
Yiyu Zhang
Hongming Li
Qiang Zheng
Publikationsdatum
09.03.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 8/2023
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-023-09519-x

Weitere Artikel der Ausgabe 8/2023

European Radiology 8/2023 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.